Monte Rosa Therapeutics, Inc. (GLUE)

CIK 1826457 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Monte Rosa Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001193125-26-384360
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005533
Aug 14, 2026SCHEDULE 13G0000902664-26-003506
Aug 6, 20268-K0001193125-26-336681
Aug 6, 202610-Q0001193125-26-336711
Jul 17, 202640001193125-26-307791
Jul 16, 20261440001950047-26-007144
Jul 16, 202640001193125-26-306110
Jul 15, 20261440001969223-26-000786
Jul 8, 2026SCHEDULE 13G/A0000080255-26-000442
Jul 7, 202640001193125-26-297558
Jul 6, 2026SCHEDULE 13D/A0001072613-26-000558
Jul 6, 202640001193125-26-296490
Jul 1, 202640001193125-26-292767
Jun 30, 202640001193125-26-290484
Jun 30, 202640001193125-26-290486
Jun 30, 20261440001950047-26-006665
Jun 29, 20261440001950047-26-006574
Jun 29, 20261440001950047-26-006612
Jun 25, 202640001193125-26-282735
Jun 25, 202640001193125-26-282740
Jun 25, 202640001193125-26-282736
Jun 24, 20261440001950047-26-006456
Jun 23, 20261440001950047-26-006406
Jun 23, 20261440001950047-26-006428